Abstract
Background
Systemic administration of lidocaine has been widely reported to provide effective analgesia in both cancer and non-malignant pain.
Case report
We report the use of intravenous lidocaine in the management of cancer-related neuropathic pain and its pivotal role in restoring function and facilitating end-of-life care at home.
References
Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB (2005) Systemic Administration of Local Anaesthetics to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis. Anesth Analg 101(6):1738–1749
Mao J, Chen L (2000) Systemic Lidocaine for Neuropathic Pain Relief. Pain 87(1):7–17
Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D (2009) A Phase II Pilot Study to Evaluate Use of Intravenous Lidocaine for Opioid-Refractory Pain in Cancer Patients. J Pain Symptom Manage 37(1):85–93
Brose WG, Cousins MJ (1991) Subcutaneous Lidocaine for Treatment of Neuropathic Cancer Pain. Pain 45(2):145–148
Jänig W (2008) What is the Mechanism Underlying Treatment of Pain by Systemic Application of Lidocaine? Pain 137(1):5–6
Lauretti GR (2008) Mechanisms of Analgesia of Intravenous Lidocaine. Rev Bras Anes 58(3):280–286
Thomas J, Kronenberg P, Cox MC, Naco GC, Wallace M, von Gunten CF (2004) Intravenous Lidocaine Relieves Severe Pain: Results of an Inpatient Hospice Chart Review. J Palliat Med 7(5):660–667
Ferrini R, Paice J (2004) How to Initiate and Monitor Infusional Lidocaine for Severe and/or Neuropathic Pain. J Support Oncol 2(1):90–94
McCleane G (2007) Intravenous Lidocaine: An Outdated or Underutilized Treatment for Pain? J Palliat Med 10(3):798–805
Tei Y, Morita T, Shishido H, Inoue S (2005) Lidocaine Intoxication at Very Small Doses in Terminally Ill Cancer Patients. J Pain Symptom Manage 30(1):85–93
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buchanan, D.D., J. MacIvor, F. A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life. Support Care Cancer 18, 899–901 (2010). https://doi.org/10.1007/s00520-010-0864-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-010-0864-3